ID
24263
Beskrivning
NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection
Nyckelord
Versioner (1)
- 2017-07-28 2017-07-28 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
28 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADO
GSK Study Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS NCT00079911
Similar models
GSK Study Randomisation Visit SUMMARY OF REVISED 1993 CLASS/FICA TION SYSTEM FOR HIV INFECTIONS AND EXPANDED SURVEILLANCE CASE DEFINITION FOR AIDS AMONG ADOLESCENTS AND ADULTS NCT00079911
C0497156 (UMLS CUI [2])
C0012634 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])